AIM
SANA icon

Aigen Investment Management’s Sana Biotechnology SANA Stock Holding History

Aigen Investment Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,171
Closed -$78.5K – 1053
2023
Q2 		$78.5K Buy
+13,171
New +$75.9K 0.01% 688

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Aigen Investment Management's SANA Position: Q3 2023 in Review

Aigen Investment Management sold out of Sana Biotechnology (SANA) in Q3 2023, closing a stake of 13,171 shares — an estimated $78.5K sold.

Aigen Investment Management first reported a position in SANA in Q2 2023 and held it in 1 quarter. The position peaked at $78.5K in Q2 2023. 136 funds tracked by Wall St. Rank hold SANA as of Q3 2023.

  • Aigen Investment Management reported no remaining Sana Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Aigen Investment Management sold 13,171 Sana Biotechnology shares in Q3 2023, an estimated $78.5K.
  • Aigen Investment Management first reported a position in Sana Biotechnology in Q2 2023 and held it in 1 quarter.
  • Aigen Investment Management's Sana Biotechnology position peaked at $78.5K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2023.

Based on Aigen Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.